VACRAX I.V. FOR INFUSION 250 mg/vial
Product details
Registration number: SIN10874P
Classification: Prescription Only
Active ingredients: ACYCLOVIR
Strength: 250 mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: ZYFAS PHARMA PTE LTD
ATC code: J05AB01
HSA approval date: 13 April 1999
Manufacturer(s): Aprogen Pharmaceuticals, Inc.
Manufacturing country/countries: KOREA, REPUBLIC OF
What are the HSA registration number and classification for VACRAX I.V. FOR INFUSION 250 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN10874P
Classification: Prescription Only
What active ingredients and strength are recorded for VACRAX I.V. FOR INFUSION 250 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: ACYCLOVIR
Strength: 250 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for VACRAX I.V. FOR INFUSION 250 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for VACRAX I.V. FOR INFUSION 250 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: ZYFAS PHARMA PTE LTD
Which manufacturers and countries are listed for VACRAX I.V. FOR INFUSION 250 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Aprogen Pharmaceuticals, Inc.
Manufacturing country/countries: KOREA, REPUBLIC OF
Where can I look up VACRAX I.V. FOR INFUSION 250 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN10874P or the exact product name VACRAX I.V. FOR INFUSION 250 mg/vial. The general register link does not preselect this product.
What are the source dates for this VACRAX I.V. FOR INFUSION 250 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this VACRAX I.V. FOR INFUSION 250 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN10874P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)